This week saw both Regenxbio and Solid Bio report new data with their gene therapy candidates for Duchenne muscular dystrophy ...

The pharmaceutical and biotech sectors have seen a flurry of executive movement this month, with leadership changes spanning global giants, clinical-stage biotechs, and specialist pharma companies ...

Hospitals in England have been urged to block the implementation of software developed by controversial tech firm Palantir by a coalition of patient, healthcare, worker, trade union, and consumer ...

Bristol Myers Squibb has brought one drug in the class to market – Opdualag, which combined LAG-3 drug relatlimab with PD-1 inhibitor nivolumab – but the company has subsequently been plagued by a ...

Many Americans are forced to make difficult trade-offs with living expenses and delay life events like retirement to afford health, says a new poll. The Gallup/West Health survey (PDF) of around ...

Eisai has launched a campaign to raise awareness of sleep disorders in Japan, via a partnership with smartphone app Pokémon ...

Interim results from RAINIER reveal that an 80 mg dose of povetacicept every four weeks delivered a 52% reduction in protein ...

The consequences of the US-Israel war in Iran have spilled over into the medtech sector, with a cyberattack launched against prominent US company Stryker. An Iranian hacker group has claimed ...

They are due to leave by the end of this year to set up an as-yet unnamed "independent biotechnology company to research and ...

Steve Sanghera is the CEO and co-founder of Inventus. With over 20 years of experience in technology and telecommunications, ...

The Evolution Summit, taking place May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida. Designed as an ...

Evotec has announced the next phase of its company overhaul, dubbed Horizon, that will see 800 people lose their jobs in a bid to cut €75 million in costs by the end of 2027. The layoffs follow around ...